Department of Microbiology and Immunology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Lankenau Institute for Medical Research, Wynnewood, PA, USA.
Nat Commun. 2020 Feb 21;11(1):1007. doi: 10.1038/s41467-020-14685-3.
Bacterial biofilms, especially those associated with implanted medical devices, are difficult to eradicate. Curli amyloid fibers are important components of the biofilms formed by the Enterobacteriaceae family. Here, we show that a human monoclonal antibody with pan-amyloid-binding activity (mAb 3H3) can disrupt biofilms formed by Salmonella enterica serovar Typhimurium in vitro and in vivo. The antibody disrupts the biofilm structure, enhancing biofilm eradication by antibiotics and immune cells. In mice, 3H3 injections allow antibiotic-mediated clearance of catheter-associated S. Typhimurium biofilms. Thus, monoclonal antibodies that bind a pan-amyloid epitope have potential to prevent or eradicate bacterial biofilms.
细菌生物膜,特别是那些与植入性医疗设备相关的生物膜,很难被清除。卷曲菌(Curli)淀粉样纤维是肠杆菌科(Enterobacteriaceae)形成的生物膜的重要组成部分。在这里,我们表明一种具有泛淀粉样蛋白结合活性的人源单克隆抗体(mAb3H3)可以体外和体内破坏鼠伤寒沙门氏菌(Salmonella enterica serovar Typhimurium)形成的生物膜。该抗体破坏生物膜结构,增强抗生素和免疫细胞对生物膜的清除作用。在小鼠中,3H3 注射可促进抗生素介导的导管相关鼠伤寒沙门氏菌生物膜清除。因此,结合泛淀粉样蛋白表位的单克隆抗体具有预防或清除细菌生物膜的潜力。